France's Drug Risk List Could Prompt Patients To Seek Alternatives
• By Faraz Kermani
The French Medicines Agency has published a list of potentially problematic medicines, seeking to reassure the public of its pharmacovigilance efforts in the wake of the Mediator scandal. It may not have the intended effect.
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
